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Abstract
Objective: Testicular adrenal rest tumours (TART) are a well-known complication in adult male patients
with congenital adrenal hyperplasia (CAH), with a reported prevalence of up to 94%. In adulthood, the
tumours are associated with gonadal dysfunction most probably due to longstanding obstruction of the
seminiferous tubules. The aim of our study was to determine the presence of TART and their influence
on gonadal function in childhood.
Design: Retrospective study.
Patients and methods: Scrotal ultrasound was performed in 34 children with CAH due to
21-hydroxylase deficiency who were between 2 and 18 years old. FSH, LH, testosterone and inhibin
B concentrations were measured in serum of 27 patients.
Results: TART were detected by ultrasound in 8 out of 34 (24%) children. In two of them, bilateral
tumours were found. All lesions were located in the rete testis. Seven patients had the salt-wasting type
of CAH; one patient had the simple virilising type of CAH. Mean tumour size was 4.1 mm (range 2–
8 mm). In none of the patients were the tumours palpable. Two children with TART were between 5
and 10 years old, the other six children were above 10 years old. In all children with TART, LH, FSH,
testosterone and inhibin B levels were similar to the patients without TART.
Conclusion: TART can be found in CAH children before the age of 10 years. The absence of gonadal
dysfunction in our group of children suggests that gonadal dysfunction as frequently reported in adult
CAH patients with TART develops after childhood.
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Introduction
Testicular adrenal rest tumours (TART) are frequently
found in adult males with congenital adrenal hyperplasia
(CAH) with a reported prevalence of up to 94% (1). The
tumours are always benign. However, because of their
typical locationwithin the rete testis, the tumoursmay lead
to obstruction of the seminiferous tubules with possible
gonadal dysfunctionand infertility (2). Therefore, itmaybe
important to detect and treat the tumours in an early stage.
Both ultrasound and MRI are good imaging modalities for
the detection and follow-up of TART, especially when they
are not palpable on physical examination (3).
The presence of TART in children is described mostly
in case reports (4–7) and only a limited number of
studies describe its prevalence in larger populations of
children and adults (8–10). Avila et al. detected TART by
ultrasound in 8 out of 38 male CAH patients (age 6–31
years) (9). The mean age of the patients was 14.8 years
and 7 out of the 8 patients with TART were below 18
years old. The youngest patient was 6.2 years old. The
total number of investigated patients below 18 years
was not reported. Vanzulli et al. described a prevalence
of 27% of TART in a group of 30 CAH patients between
9 and 32 years (10). In the investigation of 24 patients
below 18 years, 7 (29%) had TART. However, these
studies did not focus on childhood age and did not
present information on gonadal function.
It is suggested that adrenal rest cells in the testes are
already present in the embryological period but the onset
of tumour growth is not known. Shanklin et al. studied
autopsymaterial of patientswith CAHand detected TART
in three out of seven patients less than eight weeks old
(11). Other studies could not detect testicular tumours by
ultrasound before the age of 10 (12).
The aim of our retrospective study was to investigate
the incidence of TART in our group of male CAH
children. Furthermore, we measured FSH, LH, testoster-
one and inhibin B levels in this group of CAH children in
order to detect possible negative effects of these tumours
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on gonadal function in childhood. In our study group,
we show that TART are already present in childhood
and gonadal function is not disturbed.
Patients and methods
Patients
Scrotal ultrasound was performed in all 34 male
children with CAH due to 21-hydroxylase deficiency
who were regularly presented at our outpatient
paediatric endocrine unit. The patients were ranged in
three age categories: 1–5, 5–10 and 10–18 years old.
The mean age at the first ultrasound was 8;1
(years;months; range 2;7 to 15;0). In six children, the
first scrotal ultrasound was performed before the age of
5 years, in 19 children between 5 and 10 years and in 9
children between 10 and 18 years. Ultrasound scanning
was repeated at intervals of 1–2 years in most patients
(Fig. 1).
In all patients, the diagnosis of CAH was made on
symptoms and laboratory tests and was confirmed by
mutation analysis. Twenty-four patients had the
classical salt-wasting (SW) type, eight patients had the
simple virilising (SV) type and two patients had the late
onset (LO) type of CAH. All SW patients were diagnosed
in the first month of life with exception of patient 6 who
had uretral valves. He was falsely diagnosed as having
pseudohypoaldosteronism and was treated with salt
suppletion only in the first year of life. The diagnosis
CAH in this patient was made not before the age of 1;7
years. All patients were treated with hydrocortisone
three times a day and in the case of SW also with
fludrocortisone. During follow-up, therapy was mon-
itored each 3 months by evaluating clinical symptoms,
anthropometrical measurements (length and weight)
and biochemical measurements. Glucocorticoid dosing
was monitored by determination of 17-hydroxypro-
gesterone (17OHP) and androstenedione (A) levels in
peripheral blood collected in the morning before taking
the glucocorticoid medication in children below 4–5
years old, and by measuring 17OHP and A in three
saliva samples collected before each of the three doses
glucocorticoid medication in older children. Under-
treatment was defined as a morning androstenedione
concentration before taking the first glucocorticoid dose
above the morning reference range for pubertal stage;
overtreatment was defined as a morning androstene-
dione concentration below the morning reference range
for pubertal stage (13).
For evaluation of pubertal status the Tanner stages
were used (14). Bone maturation was determined
according to Greulich & Pyle (15) in order to determine
the hormonal control over years.
Radiological evaluation
All ultrasonographic evaluations were performed by
one out of the three paediatric radiologists in our centre
with extensive experience in scrotal ultrasound.
The imaging was done on a 500hdi Philips/ATL
model (Philips Medical systems, Bothell, WA, USA) with
multi-probe capabilities (4.5–11 mHz) and the lesions
were measured by calliper. At least three transverse and
axial images of each testis were made, with at least one
Doppler image containing the lesion(s). Testicular
tumours within the mediastinum testis can be detected
by ultrasound when they are at least 2 mm (3).
Hormone analysis
Luteinising hormone (LH), follicle-stimulating hormone
(FSH), testosteroneand inhibinB concentrations in serum
weremeasured inpatients above the age of 5 years old.We
measured LH and FSH concentrations in 27 children,
testosterone concentrations in 26 children and inhibin B
concentrations in 23 children. LH and FSH were
determined with a Fluorescence Immuno Enzymatic
Assay (Abbott) using a Random Access Analyser (Type
AxSYM, Abbott). Testosterone was assessed by RIA after
pre-purification by means of paper chromatography of
ether extracts of the samples, including correction for
procedural losses, as described previously (16, 17).
Dimeric inhibin B was quantified using a solid phase
sandwich ELISA specific for measurement of inhibin B in
human serum (Oxford Bio-Innovation Ltd, Oxford, UK).
The assaywasperformed according to themanufacturer’s
instructions.
Figure 1Overview of all scrotal ultrasound investigations in 34 male
children with congenital adrenal hyperplasia aged 2 to 18 years.
Each circle represents one ultrasound investigation. Open circle, no
TART detected; black circles, TART detected.
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Results
Radiological evaluation
Figure 1 summarises the age of the first scrotal
ultrasound and the frequency of follow-up in all 34
investigated children. TART were detected by ultra-
sound in 8 out of the 34 investigated children (24%). In
two out of them bilateral tumours were found (nos 1
and 8). The patients’ characteristics are listed in
Table 1. Seven patients had the SW type and one
patient had the SV type of CAH. In none of the patients
were tumours the palpable on physical examination. In
none of the children in the group below 5 years were
TART detected. TART were detected in two children in
the group between 5 and 10 years (10% of this age
group) and in six children in the group between 10 and
18 years old (66% of this age group). The mean tumour
size was 4.1 mm (range 2–8 mm). Two children (nos 1
and 2) showed progression of the tumour size on follow-
up ultrasound, one child (no. 7) showed regression of
tumour size. All lesions were located near the
mediastinum testis and were described as hypoechoic
round lesions (Fig. 2), occasionally with an echogenic
focus within (Fig. 3).
Gonadal function
At the time of biochemical evaluation, three patients
(nos 1, 2 and 7) had (nearly) completed puberty
(Tanner stages IV and V). Two other patients (nos 3
and 8) showed no signs of puberty (Tanner stage I). In
three patients (nos 4–6) puberty had started (Tanner
stage II). In all 27 children in whom biochemical
analysis was performed, the LH, FSH, testosterone and
inhibin B concentrations were within the normal range
for pubertal stage, with the exception of two CAH
children without TART (age 8 and 7 years old) with
isolated increased LH levels. Precocious puberty in these
patients was excluded. There was no clear difference in
laboratory values between children with and without
TART (Fig. 4).
Hormonal control
Six out of the eight children with TART had a bone age
similar to calendar age. Two children showed advanced
bone age of maximally 2 years (nos 3 and 5). Five out of
the eight children with TART were overtreated at the
time of TART diagnosis. Therefore, in these patients the
glucocorticoid medication was not increased when
Table 1 Mutation analysis, phenotype, age at diagnosis of congenital adrenal hyperplasia (CAH), age at first ultrasound, age at first
detection of testicular adrenal rest tumours (TART) and tumour size at first detection in eight CAH children with TART.
P Allele 1a Allele 2a Phenotypeb
Age at diag-
nosis of CAH
(years; months)
Age at first
ultrasound
(years; months)
Age at diag-
nosis of TART
(years; months)
Tumour size at first
detection
1 Del/conv 329–336 del SW Neonatal 13;10 13;10 L3 mm and R3 mm
2 Del/conv c.1066COT SW Neonatal 11;9 11;9 L2 mm and RK
3 Del/conv c.841GOT,
c.1066COT,
c.952COT
SW Neonatal 8;1 10;1 L4!2 mm and RK
4 IVS 2-13,
c.841GOT
c.952COT SW 0;3 7;3 7;3 L5 mm and RK
5 Del/conv Del/conv SW Neonatal 7;7 7;7 L– and R3 mm
6 c.1066COT c.1066COT SW 1;7 11;3 11;3 L– and R3 mm
7 Del/conv c.707 TOA,
c.710 TOA,
c.716 TOA
SW Neonatal 12;2 17;0 L– and R4 mm
8 c.515TOA c.707 TOA,
c.710 TOA,
c.716 TOA
SV 3;4 10;7 11;9 L6 mm and R8 mm
P, patient number.
a Nucleotides are numbered according to Higashi’s functional CYP21 sequence (26).
b SW, classic salt wasting CAH; SV, classic simple virilising CAH.
Figure 2 Scrotal ultrasound of patient 2 at the age of 13 years.
Transverse image shows a mostly hypoechogenic rounded lesion in
the left testis (arrow) near the rete testis (broken arrow).
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TART was detected. One patient (no. 2) was adequately
treated. Also in this patient glucocorticoid medication
was not increased because of the suppressed salivary
androstenedione levels during the rest of the day. Two
patients (nos 1 and 7) were undertreated at the time of
detection of TART (Table 2): Patient 1 was treated with
adequate doses of hydrocortisone but there was lack of
compliance. After TART detection, the glucocorticoid
doses were increased without any effect on tumour size
and with persistently poor compliance until the age of
18 years. In patient 7, the glucocorticoid dose was
increased after detection. Six months later the andros-
tenedione levels were suppressed and the tumour was
no longer detectable on ultrasound.
Discussion
The present study shows that in male CAH children
TART are already present in childhood with a
prevalence of 24%. This finding is in agreement with
previous studies (9, 10). However, our study is the first
focusing exclusively on childhood age in a larger patient
group and gives additional information about gonadal
function of CAH children with and without TART. None
of the tumours were detectable by palpation and none of
the children with testicular tumours showed signs of
gonadal dysfunction.
The aetiology and pathogenesis of TART in CAH
patients are not completely understood. Several studies
documented the production of adrenal-specific steroids
or the presence of adrenal-specific enzymes in these
tumours (18, 19). Therefore, TART are thought to arise
from aberrant adrenal cells in the testes. In the
embryological period, cells destined to become adrenal
or gonadal cells derive from neighbouring areas of the
coelomic epithelium and are morphologically identical
(20). During further development, a limited number of
‘adrenal’ cells may migrate together with the descend-
ing testis. Aberrant adrenal tissue within the testes is
reported with an incidence of 7.5–15% (autopsy and
surgical findings) in healthy neonates and normally
regresses in early infancy (21). Our data suggest that
the incidence of aberrant adrenal tissue in the testes is
probably underestimated, because under unstimulated
conditions aberrant adrenal tissue is difficult to detect.
In CAH patients, aberrant adrenal tissue may grow due
to chronically elevated levels of adrenocorticotrophin
Figure 3 Scrotal ultrasound of patient 6 at the age of 18 years
showing a hypoechoic lesion (arrow) with an echogenic centre
(broken arrow).
Figure 4 Serum levels of LH, FSH,
testosterone and inhibin B in male CAH
children without TART (open circles) and
with TART (closed circles) related to
pubertal stages 1–5 according to Tanner.
Normal values of LH (U/l) depending on
pubertal stage (I–V): median (5–96 percen-
tiles) (27). IZ0.08 (!0.05–0.99), IIZ0.88
(0.11–2.97), IIIZ2.03 (0.51–5.42), IVZ2.89
(1.11–5.89) and VZ3.4 (1.53–6.33).
Normal values of FSH (U/L) depending on
pubertal stage: median (5–96 percentiles)
(27). IZ0.85 (0.25–2.55), IIZ1.95 (0.07–
4.39), IIIZ3.5 (0.94–9.68), IVZ3.61
(1.98–6.88) and VZ3.1 (1.38–7.52).
Normal values of testosterone (nmol/l)
depending on pubertal stage: median (5–96
percentiles) (27). I%0.2 (!0.2–0.9), IIZ1.9
(!0.2–13.4), IIIZ8.4 (0.9–21.2), IVZ17.2
(7.7–26.5) and VZ21.0 (11.3–32.3).
Normal values of inhibin B (ng/l) depending
onpubertalstage:median(5–96percentiles)
(27). IZ78 (35–182), IIZ195 (62–338),
IIIZ163 (78–323), IVZ188 (67–304) and
VZ187 (95–323).
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(ACTH) or other unknown growth promoting factors,
and may explain the increase in tumour detection by
ultrasound during childhood.
The youngest CAH patient with TART reported in the
literature was only several weeks old (11). Recently, we
detected a small testicular tumour at post-mortem
histopathological examination in a 2-year-old male
CAH patient who died in an Addisonian crisis
(unpublished data). The youngest patient with TART
in our present study was 7 years old. Therefore, it can be
speculated that tumour growth starts during childhood
or even in prenatal life.
Until now the exactmechanisms responsible for tumour
growth are uncertain. ACTH may be an important
stimulator of tumour growth, because ACTH receptors
are present on the tumour tissue, and some authors
describe a relationship between poorhormonal control and
progression of tumour growth (22, 23). Although
adequacy of substitution therapy was not systematically
assessed in our patients, none of our patients had
documented periods of poor hormonal control in early
childhood or puberty. The absence of advanced skeletal
maturation in most patients also favours the notion that
hormonal controlwas adequate in our patients.Most of the
TART were detected in children above 10 years old. It can
be suggested that hormones whose levels are increased in
puberty, such as LH, are additional stimulators of tumour
growth. The presence of LH receptors in testicular tumour
tissue supports this hypothesis (24).
It is known that TART have no malignant features.
Therefore, there seems to benoneed to treat or remove the
tumours at an early stage. However, because of the
localisation of the tumours in the rete testis, the tumours
may compress the seminiferous tubules leading to
obstructive azoospermia and irreversible damage of the
testes (2, 25). Therefore, it is important to detect and treat
the tumours before permanent damage of the testis has
occurred. Because the growth promoting factors are still
unclear, strategies to prevent tumour growth are difficult
to define. It has to be investigated whether testis-sparing
surgery at an early stage may prevent irreversible
testicular damage in later life.
In summary, our study shows that TART are
frequently found already in young CAH children.
Based on the absence of signs of gonadal dysfunction
in our group of children, it seems that gonadal
dysfunction, as frequently reported in adult patients,
develops after childhood in patients with longstanding
tumours. Further studies are necessary to determine
whether it is possible to prevent testicular damage by
surgical removal of the tumours already in childhood.
References
1 Stikkelbroeck NMML, Otten BJ, Pasic A, Jager GJ, Sweep CGJ,
Noordam K & Hermus ARMM. High prevalence of testicular
adrenal rest tumours, impaired spermatogenesis, and Leydig cell
failure in adolescent and adult males with congenital adrenal
hyperplasia. Journal of Clinical Endocrinology and Metabolism 2001
86 5721–5728.
2 Claahsen-van der Grinten HL, Otten BJ, Hermus ARMM, Sweep
CGJ, Hulsbergen-van de Kaa CA. Testicular adrenal rest tumours
in patients with congenital adrenal hyperplasia can cause severe
testicular damage. Fertility and Sterility 2007 (In press).
3 Stikkelbroeck NMML, Suliman HM, Otten BJ, Hermus ARMM,
Blickman J & Jager GJ. Testicular adrenal rest tumours in
postpubertal males with congenital adrenal hyperplasia: sono-
graphic and MR features. European Radiology 2003 13
1597–1603.
4 Newell ME, Lippe BM & Ehrlich RM. Testis tumors associated with
congenital adrenal hyperplasia: a continuing diagnostic and
therapeutic dilemma. Journal of Urology 1977 117 256–258.
5 Boulware SD. Case report. An unusual case of precocious puberty.
Current Opinion in Pediatrics 1997 9 443–446.
6 Erdogan S, Ergin M, Cevlik F, Yuksel B, Tuncer R, Tunali N &
Polat S. Testicular adrenal rest hyperplasia due to 21-hydroxylase
deficiency: a case resport. Endocrine Pathology 2006 17 83–87.
7 Walker BR, Skoog SJ, Winslow BH, Canning DA & Tank ES. Testis
sparing surgery for steroid unresponsive testicular tumours of the
adrenogenital syndrome. Journal of Urology 1997 157
1460–1463.
8 Willi U, Atares M, Prader A & ZachmannM. Testicular adrenal-like
tissue (TALT) in congenital adrenal hyperplasia: detection by
ultrasonography. Pediatric Radiology 1991 21 284–287.
9 Avila NA, Premkumar A, Shawker TH, Jones JV, Laue L &
Cutler GB. Testicular adrenal rest tissue in congenital adrena
hyperplasia: findings at gray-scale and color Doppler US. Radiology
1996 198 99–104.
Table 2 Salivary levels of androstenedione in eight male children at the time of testicular adrenal rest tumours detection.
P Pubertal stagea A morning (nmol/l)b A noon (nmol/l)b A evening (nmol/l)b Treatmentc
1 V 0.94 0.65 0.5 Undertreatment
2 V 0.25 0.1 0.08 Adequate treatment
3 I 0.14 !0.06 0.04 Overtreatment
4 I !0.02 !0.02 !0.02 Overtreatment
5 I 0.07 !0.03 !0.036 Overtreatment
6 I 0.08 0.04 !0.04 Overtreatment
7 IV 2.7 1.6 0.62 Undertreatment
8 I 0.061 0.03 !0.02 Overtreatment
P, patient number; A, salivary androstenedione levels. Salivary samples were collected three times a day before taking the glucocorticoid medication
(morning between 0700 and 0900 h; noon between 1300 and 1500 h and evening between 2100 and 2300 h).
a Pubertal stage according to Tanner (14).
b Normal salivary androstenedione values: Tanner I: 0.02–0.25 nmol/l and Tanners II–V: 0.14–0.63 nmol/l (13).
c For definitions of undertreatment, overtreatment and adequate treatment see text.
Testicular tumours in CAH children 343EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007) 157
www.eje-online.org
10 Vanzulli A, Delmaschino A, Paesano P, Braggion F, Livieri C,
Angeli E, Tomasi G & Gatti C. Testicular masses in association with
adrenogenital syndrome: US findings. Radiology 1992 183
425–429.
11 Shanklin DR, Richardson AP, Jr & Rothstein G. Testicular hilar
nodules in adrenogenital syndrome. American Journal of Diseases of
Children 1963 106 243–250.
12 Pierre P, Despert F, Tranquart F, Chabrolle C, Sonnet E, Baron S &
Lecomte P. Adrenal rest tissue in gonads in 66 French patients
with congenital adrenal hyperplasia (classic 21 hydroxylase
deficiency). Endocrine Society 2006 21 P3–758.
13 Otten BJ, Wellen JJ, Rijken JC, Stoelinga GB & Benraad TJ. Salivary
and plasma androstenedione and 17-hydroxyprogesterone levels
in congenital adrenal hyperplasia. Journal of Clinical Endocrinology
and Metabolism 1983 57 1150–1154.
14 Tanner JM & Whitehouse RH. Clinical longitudinal standards for
height, weight, height velocity, weight velocity, and stages of
puberty. Archives of Disease in Childhood 1976 51 170–179.
15 Greulich WW & Pyle SI. Radiographic Atlas of Skeletal Development
of the Hand and Wrist. 2 Stanford, California: Stanford University
Press, 1959.
16 Swinkels LMJW, van Hoof HJC, Ross HA, Smals AGM& Benraad TJ.
Low ratio of androstenedione to testosterone in plasma and saliva
of hirsute women. Clinical Chemistry 1992 38 1819–1823.
17 Swinkels LMJW, Ross HA & Benraad TJ. A symmetric dialysis
method for the determination of free testosterone in human
plasma. Clinica Chimica Acta 1987 165 341–349.
18 Clark RV, Albertson BD, Munabi A, Cassorla F, Aguilera G,
Warren DW, Sherins RJ & Loriaux DL. Steroidogenic enzyme
activities, morphology and receptor studies of a testicular adrenal
rest in a patient with congenital adrenal hyperplasia. Journal of
Clinical Endocrinology and Metabolism 1990 70 1408–1413.
19 Bercovici JP, Fiet J, Gibault L, Volant L, Abalain JH, Floch HH,
Sonnet E & Fournier G. Testicular adrenal rest tumours in salt
wasting congenital adrenal hyperplasia (in vivo and in vitro
studies). Journal of Steroid Biochemistry and Molecular Biology 2005
93 67–72.
20 Mesinao S & Jaffe RB. Developmental and functional biology of the
primate fetal adrenal cortex. Endocrine Reviews 1997 18
378–403.
21 Sullivan JG, Gomel M & Kinder RB. Ectopic adrenocortical tissue
found at groin exploration in children: incidence in relation to
diagnosis, age and sex. BJU International 2005 95 407–410.
22 Stikkelbroeck NML, Hermus ARMM, Suliman HM, Jager GJ &
Otten BJ. Asymptomatic testicular adrenal rest tumours in
adolescent and adult males with congenital adrenal hyperplasia:
basal and follow-up investigation after 2.6 years. Journal of
Pediatric Endocrinology and Metabolism 2004 17 6645–6653.
23 Claahsen-van der Grinten HL, Otten BJ, Sweep CGJ, Hermus
ARMM. Repeated successful induction of fertility after replacing
hydrocortisone by equivalent doses of dexamethasone in a patient
with congenital adrenal hyperplasia and testicular adrenal rest
tumors. Fertility and Sterility 2007 (Epub).
24 Benvenga S, Smedile G, Lo GF & Trimachi F. Testicular adrenal
rests: evidence for luteinizing hormone receptors and for distinct
types of testicular nodules differing for their autonomization.
European Journal of Endocrinology 1999 141 231–237.
25 Claahsen-van der Grinten HL, Otten BJ, Takahashi S,
Meuleman EJ, Hulsbergen-van de Kaa C, Sweep CGJ &
Hermus ARMM. Testicular adrenal rest tumours in adult males
with congenital adrenal hyperplasia: evaluation of pituitary-
gonadal function before and after successful testis-sparing surgery
in 8 patients. Journal of Clinical Endocrinology and Metabolism 2007
92 612–615.
26 Higashi Y, Yoshioka H, Yamane M, Gotoh O & Fujii-Kuriyama Y.
Complete nucleotide sequence of two steroid 21-hydroxylase genes
tandemly arranged in human chromosome: a pseudogene and a
genuine gene. PNAS 1986 83 2841–2845.
27 Andersson A-M, Juul A, Petersen JH, Mueller J, Groome NP &
Skakkebaek NE. Serum inhibin B in healthy pubertal and
adolescent boys: relation to age, stage of puberty and follicle-
stimulating hormone, luteinizing hormone, testosterone and
estradiol levels. Journal of Clinical Endocrinology and Metabolism
1997 82 3976–3981.
Received 27 March 2007
Accepted 28 May 2007
344 H L Claahsen-van der Grinten and others EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007) 157
www.eje-online.org
